Bayer Aktiengesellschaft Profit Margin

The latest profit margin for BAYN.DE is -3.84% as of June 2026. That compares with -7.4% in the prior-year period — up 48.1% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Bayer Aktiengesellschaft's historical trend and sector peers before judging valuation or financial health.

Over the past year, BAYN.DE's profit margin moved from -7.4% to -3.84% — a 48.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bayer Aktiengesellschaft's valuation or profitability profile.

Against Healthcare companies, BAYN.DE currently prints -3.84% for profit margin, while the sector average sits near 9.48%. That is roughly 140.5% below the sector mean. Large gaps often invite a closer look at Bayer Aktiengesellschaft's growth, margins, and balance sheet.

Profit Margin shows how effectively Bayer Aktiengesellschaft converts resources into returns. At -3.84%, BAYN.DE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -7.4% in the prior-year period — up 48.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BAYN.DE's profit margin (-3.84%), review year-over-year change from -7.4%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.